Pretreatment FMS like Tyrosine kinase-3 Internal Tandem duplication (FLT3-ITD) Mutant Allele Burden Does Not Predict Response to the Combination of Sorafenib and Azacytidine in Patients with Relapsed or High Risk Elderly Untreated Acute Myeloid Leukemia
Title:
Pretreatment FMS like Tyrosine kinase-3 Internal Tandem duplication (FLT3-ITD) Mutant Allele Burden Does Not Predict Response to the Combination of Sorafenib and Azacytidine in Patients with Relapsed or High Risk Elderly Untreated Acute Myeloid Leukemia
Author:
George, Binsah Cortes, Jorge Cabrero, Monica Jain, Nitin Konopleva, Marina Andreeff, Michael Tapan, Kadia Pierce, Sherry Dellasala, Sara Borthakur, Gautham Jabbour, Elias Garcia-Manero, Guillermo Kantarjian, Hagop Ravandi, Farhad